EBOS Group: 1H23 Result — In the Waiting Room
EBOS Group (EBO) reported a strong 1H23 result in-line with our expectations (ahead of consensus) showcasing +30% NPAT growth versus 1H22; While we...
236 Views
EBOS Group (EBO): 1H23 Result – Initial Impressions
EBOS Group (EBO) delivered a solid 1H23 result broadly in-line with our expectations; Underlying NPAT was A$141.6m (FB; A$143.7m, consensus;...
197 Views
EBOS Group: 1H23 Preview — Any Signs of Slowing?
We expect EBOS Group (EBO) to report a solid 1H23 result with little surprises (given 1Q23 was pre-released) on Wednesday, 22 February 2023, and we...
258 Views
EBOS Group: Assessing the Chemist
The renewal of EBOS Group's (EBO) Chemist Warehouse (CW) contract is a key question for investors in 2023; We have undertaken analysis of the...
187 Views
EBOS Group: 2022 Investor Day — Fulfilling the Orders
EBOS Group's (EBO) 2022 investor day (only its second ever) had little surprises, which highlighted its strong market positioning, extensive...
351 Views